Veracyte, Inc. VCYT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.50% | 17.28% | 16.91% | 16.01% | 16.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.50% | 17.28% | 16.91% | 16.01% | 16.41% |
| Cost of Revenue | 3.54% | 4.81% | 6.82% | 5.50% | 22.07% |
| Gross Profit | 23.47% | 22.62% | 21.28% | 20.78% | 14.15% |
| SG&A Expenses | 0.70% | -0.23% | 2.00% | 9.90% | 3.02% |
| Depreciation & Amortization | 0.23% | -5.72% | -8.13% | -11.42% | -15.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.55% | 6.39% | 5.00% | 6.45% | 7.55% |
| Operating Income | 80.85% | 141.56% | 196.65% | 203.10% | 367.40% |
| Income Before Tax | 281.34% | 300.50% | 158.69% | 164.92% | 479.51% |
| Income Tax Expenses | -1,340.40% | -41.65% | 34.61% | 15.07% | -36.83% |
| Earnings from Continuing Operations | 318.41% | 334.72% | 166.31% | 174.89% | 427.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 318.41% | 334.72% | 166.31% | 174.89% | 427.11% |
| EBIT | 80.85% | 141.56% | 196.65% | 203.10% | 367.40% |
| EBITDA | 54.33% | 85.22% | 105.49% | 93.01% | 109.66% |
| EPS Basic | 311.22% | 323.61% | 159.69% | 168.82% | 375.89% |
| Normalized Basic EPS | 70.50% | 100.97% | 156.23% | 159.37% | 134.44% |
| EPS Diluted | 305.89% | 325.03% | 161.37% | 174.97% | 349.37% |
| Normalized Diluted EPS | 68.09% | 99.30% | 157.05% | 160.39% | 135.25% |
| Average Basic Shares Outstanding | 2.06% | 2.05% | 2.15% | 2.75% | 3.76% |
| Average Diluted Shares Outstanding | 2.99% | 2.41% | 1.65% | 2.98% | 4.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |